£137.00

Springer Regulation of Cancer Immune Checkpoints: Molecular and Cellular Mechanisms and Therapy: 1248 (Advances in Experimental Medicine and Biology, 1248)

Price data checked 2 days ago

View at Amazon

Price History & Forecast

Last 89 days • 89 data points

Historical
Generating forecast...
£137.00 £136.71 £136.78 £136.84 £136.90 £136.96 £137.03 05 February 2026 27 February 2026 21 March 2026 12 April 2026 04 May 2026

Price Distribution

Price distribution over 89 days • 1 price levels

Days at Price
89 days 0 22 45 67 89 £137 Days at Price

Price Analysis

Most common price: £137 (89 days, 100.0%)

Price range: £137 - £137

Price levels: 1 different prices over 89 days

Description

This book systematically reviews the most important findings on cancer immune checkpoints, sharing essential insights into this rapidly evolving yet largely unexplored research topic. The past decade has seen major advances in cancer immune checkpoint therapy, which has demonstrated impressive clinical benefits. The family of checkpoints for mediating cancer immune evasion now includes CTLA-4, PD-1/PD-L1, CD27/CD70, FGL-1/LAG-3, Siglec-15, VISTA (PD-1L)/VSIG3, CD47/SIRPA, APOE/LILRB4, TIGIT, and many others. Despite these strides, most patients do not show lasting remission, and some cancers have been completely resistant to the therapy. The potentially lethal adverse effects of checkpoint blockade represent another major challenge, the mechanisms of which remain poorly understood. Compared to the cancer signaling pathways, such as p53 and Ras, mechanistic studies on immune checkpoint pathways are still in their infancy. To improve the responses to checkpoint blockade therapy and limit the adverse effects, it is essential to understand the molecular regulation of checkpoint molecules in both malignant and healthy cells/tissues. This book begins with an introduction to immune checkpoint therapy and its challenges, and subsequently describes the regulation of checkpoints at different levels. In closing, it discusses recent therapeutic developments based on mechanistic findings, and outlines goals for future translational studies. The book offers a valuable resource for researchers in the cancer immunotherapy field, helping to form a roadmap for checkpoint regulation and develop safer and more effective immunotherapies.

Product Specifications

Format
hardcover
Domain
Amazon UK
Release Date
18 March 2020
Listed Since
20 January 2020

Barcode

No barcode data available

Similar Products You Might Like

Cell Signaling & Molecular Targets in Cancer
82% match

Cell Signaling & Molecular Targets in Cancer

Springer

£107.98 04 May 2026
Cell Signaling & Molecular Targets in Cancer
80% match

Cell Signaling & Molecular Targets in Cancer

Springer

£43.99 04 May 2026
Experimental and Applied Immunotherapy
78% match

Experimental and Applied Immunotherapy

Humana

£140.31 04 May 2026
The Heterogeneity of Cancer Metabolism: 1311 (Advances in Experimental Medicine and Biology, 1311)
77% match

The Heterogeneity of Cancer Metabolism: 1311 (Advances in Experimental Medicine and Biology, 1311)

Springer

£40.29 04 May 2026
Precision Medicine in Oncology
77% match

Precision Medicine in Oncology

Wiley-Blackwell

£132.63 04 May 2026
Non-Small Cell Lung Cancer: New Research (Cancer Etiology, Diagnosis and Treatments)
77% match

Non-Small Cell Lung Cancer: New Research (Cancer Etiology, Diagnosis and Treatments)

£65.70 04 May 2026
Quantum Chemistry Methods for Oncological Drugs
77% match

Quantum Chemistry Methods for Oncological Drugs

Elsevier

£133.05 04 May 2026
Survivors of Childhood and Adolescent Cancer: A Multidisciplinary Approach (Pediatric Oncology)
76% match

Survivors of Childhood and Adolescent Cancer: A Multidisciplinary Approach (Pediatric Oncology)

Springer

£104.18 04 May 2026
Gynecological Cancers: Genetic and Epigenetic Targets and Drug Development (Current Clinical Oncology)
76% match

Gynecological Cancers: Genetic and Epigenetic Targets and Drug Development (Current Clinical Oncology)

Springer

£71.91 04 May 2026
Modification of Radiation Response: Cytokines, Growth Factors and Other Biological Targets (Medical Radiology / Diagnostic Imaging)
76% match

Modification of Radiation Response: Cytokines, Growth Factors and Other Biological Targets (Medical Radiology / Diagnostic Imaging)

Springer

£53.53 04 May 2026
Clinical Ophthalmic Oncology: Retinoblastoma
76% match

Clinical Ophthalmic Oncology: Retinoblastoma

Springer

£70.21 04 May 2026
Cancer II: 28 (Topics in Medicinal Chemistry, 28)
75% match

Cancer II: 28 (Topics in Medicinal Chemistry, 28)

Springer

£199.19 04 May 2026
Chemosensitivity Testing in Oncology: 161 (Recent Results in Cancer Research, 161)
75% match

Chemosensitivity Testing in Oncology: 161 (Recent Results in Cancer Research, 161)

Springer

£121.73 04 May 2026
Lymphocyte Trafficking in Health and Disease (Progress in Inflammation Research)
75% match

Lymphocyte Trafficking in Health and Disease (Progress in Inflammation Research)

Birkhauser

£79.82 04 May 2026
Dipeptidyl Aminopeptidases: Basic Science and Clinical Applications: 575 (Advances in Experimental Medicine and Biology, 575)
74% match

Dipeptidyl Aminopeptidases: Basic Science and Clinical Applications: 575 (Advances in Experimental Medicine and Biology, 575)

Springer

£118.13 04 May 2026
Rectal Cancer: International Perspectives on Multimodality Management (Current Clinical Oncology)
74% match

Rectal Cancer: International Perspectives on Multimodality Management (Current Clinical Oncology)

Humana

£80.64 04 May 2026
Pulmonary Dysfunction and Disease: 934 (Advances in Experimental Medicine and Biology, 934)
74% match

Pulmonary Dysfunction and Disease: 934 (Advances in Experimental Medicine and Biology, 934)

Springer

£73.85 04 May 2026
Epigenetic Mechanisms in Breast Cancer Therapy and Resistance (Advances in Experimental Medicine and Biology, 1465)
74% match

Epigenetic Mechanisms in Breast Cancer Therapy and Resistance (Advances in Experimental Medicine and Biology, 1465)

Springer

£127.59 04 May 2026
Targeting the DNA Damage Response for Cancer Therapy: 186 (Cancer Treatment and Research, 186)
74% match

Targeting the DNA Damage Response for Cancer Therapy: 186 (Cancer Treatment and Research, 186)

Springer

£73.10 04 May 2026
Transcription Factors: Normal and Malignant Development of Blood Cells (Wiley-Liss Publication)
74% match

Transcription Factors: Normal and Malignant Development of Blood Cells (Wiley-Liss Publication)

Wiley

£140.00 04 May 2026
Cancer Immunology and Genetics: An Interdisciplinary Approach: 23 (Interdisciplinary Cancer Research, 23)
74% match

Cancer Immunology and Genetics: An Interdisciplinary Approach: 23 (Interdisciplinary Cancer Research, 23)

Springer

£155.09 04 May 2026
Frontiers in Cancer Research: Evolutionary Foundations, Revolutionary Directions
74% match

Frontiers in Cancer Research: Evolutionary Foundations, Revolutionary Directions

Springer

£112.41 04 May 2026
Chemokines and Skin: Progress in Inflammation Research
74% match

Chemokines and Skin: Progress in Inflammation Research

Birkhauser

£80.56 04 May 2026
Infectious Complications in Biologic and Targeted Therapies
73% match

Infectious Complications in Biologic and Targeted Therapies

Springer

£80.64 04 May 2026